# Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension

> **NCT02426177** · PHASE3 · UNKNOWN · sponsor: **Dow University of Health Sciences** · enrollment: 98 (estimated)

## Conditions studied

- Postnatal Hypertension

## Interventions

- **DRUG:** Labetalol
- **DRUG:** Nifedipine

## Key facts

- **NCT ID:** NCT02426177
- **Lead sponsor:** Dow University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-12
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2015-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02426177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02426177, "Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02426177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*